284 related articles for article (PubMed ID: 31230029)
1. Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review.
Thurtle D; Rossi SH; Berry B; Pharoah P; Gnanapragasam VJ
BMJ Open; 2019 Jun; 9(6):e029149. PubMed ID: 31230029
[TBL] [Abstract][Full Text] [Related]
2. An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review.
Raymond E; O'Callaghan ME; Campbell J; Vincent AD; Beckmann K; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti K
Radiat Oncol; 2017 Mar; 12(1):56. PubMed ID: 28327203
[TBL] [Abstract][Full Text] [Related]
3. The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.
Gnanapragasam VJ; Bratt O; Muir K; Lee LS; Huang HH; Stattin P; Lophatananon A
BMC Med; 2018 Feb; 16(1):31. PubMed ID: 29490658
[TBL] [Abstract][Full Text] [Related]
4. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.
Kunath F; Grobe HR; Rücker G; Motschall E; Antes G; Dahm P; Wullich B; Meerpohl JJ
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009266. PubMed ID: 24979481
[TBL] [Abstract][Full Text] [Related]
6. Decision-making tools in prostate cancer: from risk grouping to nomograms.
Fontanella P; Benecchi L; Grasso A; Patel V; Albala D; Abbou C; Porpiglia F; Sandri M; Rocco B; Bianchi G
Minerva Urol Nefrol; 2017 Dec; 69(6):556-566. PubMed ID: 28376608
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
8. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
[TBL] [Abstract][Full Text] [Related]
9. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
Frampton GK; Jones J; Rose M; Payne L
Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
[TBL] [Abstract][Full Text] [Related]
10. Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity.
O'Callaghan ME; Raymond E; Campbell J; Vincent AD; Beckmann K; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti K
Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):378-388. PubMed ID: 28585573
[TBL] [Abstract][Full Text] [Related]
11. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.
Campbell JM; Raymond E; O'Callaghan ME; Vincent AD; Beckmann KR; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti KL
Clin Genitourin Cancer; 2017 Oct; 15(5):e827-e834. PubMed ID: 28666689
[TBL] [Abstract][Full Text] [Related]
12. Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials.
Martínez-González NA; Plate A; Senn O; Markun S; Rosemann T; Neuner-Jehle S
Swiss Med Wkly; 2018; 148():w14584. PubMed ID: 29473938
[TBL] [Abstract][Full Text] [Related]
13. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.
Sammon JD; Abdollah F; D'Amico A; Gettman M; Haese A; Suardi N; Vickers A; Trinh QD
Eur Urol; 2015 Nov; 68(5):756-65. PubMed ID: 25819724
[TBL] [Abstract][Full Text] [Related]
14. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
Seidenfeld J; Samson DJ; Aronson N; Albertson PC; Bayoumi AM; Bennett C; Brown A; Garber A; Gere M; Hasselblad V; Wilt T; Ziegler K
Evid Rep Technol Assess (Summ); 1999 May; (4):i-x, 1-246, I1-36, passim. PubMed ID: 11098244
[TBL] [Abstract][Full Text] [Related]
15. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
Belkora J; Chan JM; Cooperberg MR; Neuhaus J; Stupar L; Weinberg T; Broering JM; Tenggara I; Cowan JE; Rosenfeld S; Kenfield SA; Van Blarigan EL; Simko JP; Witte J; Carroll PR
Cancer Med; 2020 Jan; 9(1):125-132. PubMed ID: 31714037
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of methodological quality of model development studies predicting prognostic outcome for resectable pancreatic cancer.
Bradley A; Van Der Meer R; McKay CJ
BMJ Open; 2019 Aug; 9(8):e027192. PubMed ID: 31439598
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review.
Beyer K; Moris L; Lardas M; Haire A; Barletta F; Scuderi S; Molnar M; Herrera R; Rauf A; Campi R; Greco I; Shiranov K; Dabestani S; van den Broeck T; Arun S; Gacci M; Gandaglia G; Omar MI; MacLennan S; Roobol MJ; Farahmand B; Vradi E; Devecseri Z; Asiimwe A; Zong J; Maclennan SJ; Collette L; NDow J; Briganti A; Bjartell A; Van Hemelrijck M;
BMJ Open; 2022 Apr; 12(4):e058267. PubMed ID: 35379637
[TBL] [Abstract][Full Text] [Related]
18. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
Cooperberg MR; Pasta DJ; Elkin EP; Litwin MS; Latini DM; Du Chane J; Carroll PR
J Urol; 2005 Jun; 173(6):1938-42. PubMed ID: 15879786
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
